MedPath

ENTYVIO

ENTYVIO

Approved
DIN Number

02436841

Drug Class

Human

Market Date

Apr 21, 2015

Company
HC

takeda canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02436841
AIG Number0156530001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L04AG05 VEDOLIZUMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification90:24.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

VEDOLIZUMABActive
Strength: 300 MG / VIAL
Monograph: VEDOLIZUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.